| __timestamp | Perrigo Company plc | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 152500000 | 7459000 |
| Thursday, January 1, 2015 | 187800000 | 11831000 |
| Friday, January 1, 2016 | 184000000 | 25705000 |
| Sunday, January 1, 2017 | 167700000 | 46181000 |
| Monday, January 1, 2018 | 218600000 | 59497000 |
| Tuesday, January 1, 2019 | 187400000 | 65003000 |
| Wednesday, January 1, 2020 | 177700000 | 74506000 |
| Friday, January 1, 2021 | 122000000 | 126006000 |
| Saturday, January 1, 2022 | 123100000 | 126215000 |
| Sunday, January 1, 2023 | 122500000 | 120161000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Perrigo Company plc and Protagonist Therapeutics, Inc. have demonstrated contrasting R&D investment strategies. Perrigo, a global leader in over-the-counter health products, has seen its R&D expenses fluctuate, peaking in 2018 with a 20% increase from 2014. However, recent years show a decline, with 2023 figures dropping by 44% from their 2018 high.
Conversely, Protagonist Therapeutics, a clinical-stage biopharmaceutical company, has consistently ramped up its R&D spending. From a modest start in 2014, their investment surged by over 1,500% by 2022, reflecting their commitment to pioneering new therapies. This divergence highlights the strategic differences between established and emerging players in the pharmaceutical sector, offering insights into their future growth trajectories.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Perrigo Company plc
Comparing Innovation Spending: Amgen Inc. and Protagonist Therapeutics, Inc.
Research and Development Investment: Gilead Sciences, Inc. vs Protagonist Therapeutics, Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Protagonist Therapeutics, Inc.
Comparing Innovation Spending: GSK plc and Perrigo Company plc
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Perrigo Company plc
Comparing Innovation Spending: Neurocrine Biosciences, Inc. and Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for Jazz Pharmaceuticals plc and Perrigo Company plc
Amneal Pharmaceuticals, Inc. or Perrigo Company plc: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Perrigo Company plc vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Perrigo Company plc vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Viridian Therapeutics, Inc.